Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus

Vaccine

Volumn 31, Issue 41, 2013, Pages 4508-4515

  Li, Xiangdong ^a   Galliher Beckley, Amy ^a   Huang, Hongzhou ^a   Sun, Xiuzhi ^a   Shi, Jishu ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Adjuvant; Hydrogel; Modified live vaccine; PRRSV

Indexed keywords

ADJUVANT; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 8; LIVE VACCINE; NANOFIBER; NEUTRALIZING ANTIBODY; PEPTIDE; THORIUM; TUMOR NECROSIS FACTOR ALPHA; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTERIVIRUS; ARTERIVIRUS INFECTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VARIABILITY; HEMAGGLUTINATION INHIBITION; HUMORAL IMMUNITY; HYDROGEL; IMMUNITY; IMMUNIZATION; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SWINE; VIREMIA; VIRUS VIRULENCE;

ADJUVANT; HYDROGEL; MODIFIED LIVE VACCINE; PRRSV;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; HYDROGEL; INTERFERON-GAMMA; NANOFIBERS; PEPTIDES; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SWINE; T-LYMPHOCYTE SUBSETS; VACCINES, ATTENUATED; VIRAL VACCINES; VIREMIA;

EID: 84883600933     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.080     Document Type: Article

References (33)

1. Tian K., Yu X., Zhao T., Feng Y., Cao Z., Wang C., et al. Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark. PLoS ONE 2007, 2:e526.
2. Chand R.J., Trible B.R., Rowland R.R. Pathogenesis of porcine reproductive and respiratory syndrome virus. Current Opinion in Virology 2012, 256-263.
3. Rowland R.R., Lunney J., Dekkers J. Control of porcine reproductive and respiratory syndrome (PRRS) through genetic improvements in disease resistance and tolerance. Frontiers in Genetics 2012, 3:260.
4. Thanawongnuwech R., Suradhat S. Taming PRRSV: revisiting the control strategies and vaccine design. Virus Research 2010, 154:133-140.
5. Botner A., Strandbygaard B., Sorensen K.J., Have P., Madsen K.G., Madsen E.S., et al. Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine. Veterinary Record 1997, 141:497-499.
6. Deville S., Arous J.B., Ionkoff G., Kukushkin S., Bertranda F., Baybikov T., et al. Load reduction in live PRRS vaccines using oil and polymer adjuvants. Procedia in Vaccinology 2012, 6:134-140.
7. Dwivedi V., Manickam C., Patterson R., Dodson K., Murtaugh M., Torrelles J.B., et al. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant. Vaccine 2011, 29:4058-4066.
8. Billiet T., Vandenhaute M., Schelfhout J., Van Vlierberghe S., Dubruel P. A review of trends and limitations in hydrogel-rapid prototyping for tissue engineering. Biomaterials 2012, 33:6020-6041.
9. Hosseinkhani H. 3D in vitro technology for drug discovery. Current Drug Safety 2012, 7:37-43.
10. Huang H.Z., Shi J.S., Laskin J., Liu Z.Y., McVey D.S., Sun X.Z.S. Design of a shear-thinning recoverable peptide hydrogel from native sequences and application for influenza H1N1 vaccine adjuvant. Soft Matter 2011, 7:8905-8912.
11. Li X., Galliher-Beckley A., Nietfeld J., Faaberg K., Shi J. Montanide TM Gel01 ST adjuvant enhances PRRS modified live vaccine efficacy by regulating porcine humoral and cellular immune responses. World Journal of Vaccines 2013, 3:1-9.
12. Ferrari L., Martelli P., Saleri R., De Angelis E., Cavalli V., Bresaola M., et al. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection. Veterinary Immunology and Immunopathology 2013, 151:193-206.
13. Hu J., Zhang C. Porcine reproductive and respiratory syndrome virus vaccines: current status and strategies to a universal vaccine. Transboundary and Emerging Diseases 2013.
14. Charerntantanakul W. Adjuvants for porcine reproductive and respiratory syndrome virus vaccines. Veterinary Immunology and Immunopathology 2009, 129:1-13.
15. Dwivedi V., Manickam C., Binjawadagi B., Joyappa D., Renukaradhya G.J. Biodegradable nanoparticle-entrapped vaccine induces cross-protective immune response against a virulent heterologous respiratory viral infection in pigs. PLoS ONE 2012, 7:e51794.
16. Huang H., Herrera A.I., Luo Z., Prakash O., Sun X.S. Structural transformation and physical properties of a hydrogel-forming peptide studied by NMR, transmission electron microscopy, and dynamic rheometer. Biophysical Journal 2012, 103:979-988.
17. Hu J., Ma P.X. Nano-fibrous tissue engineering scaffolds capable of growth factor delivery. Pharmaceutical Research 2011, 28:1273-1281.
18. Lee S., Kim J.S., Chu H.S., Kim G.W., Won J.I., Jang J.H. Electrospun nanofibrous scaffolds for controlled release of adeno-associated viral vectors. Acta Biomaterialia 2011, 7:3868-3876.
19. Webber M.J., Matson J.B., Tamboli V.K., Stupp S.I. Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response. Biomaterials 2012, 33:6823-6832.
20. Guo B., Lager K.M., Henningson J.N., Miller L.C., Schlink S.N., Kappes M.A., et al. Experimental infection of United States swine with a Chinese highly pathogenic strain of porcine reproductive and respiratory syndrome virus. Virology 2013, 435:372-384.
21. Sun Y., Han M., Kim C., Calvert J.G., Yoo D. Interplay between interferon-mediated innate immunity and porcine reproductive and respiratory syndrome virus. Viruses 2012, 4:424-446.
22. Zhu L., Zhou Y., Tong G. Mechanisms of suppression of interferon production by porcine reproductive and respiratory syndrome virus. Acta Virologica 2012, 56:3-9.
23. Wesley R.D., Lager K.M., Kehrli M.E. Infection with Porcine reproductive and respiratory syndrome virus stimulates an early gamma interferon response in the serum of pigs. Canadian Journal of Veterinary Research 2006, 70:176-182.
24. Lunney J.K., Fritz E.R., Reecy J.M., Kuhar D., Prucnal E., Molina R., et al. Interleukin-8, interleukin-1beta, and interferon-gamma levels are linked to PRRS virus clearance. Viral Immunology 2010, 23:127-134.
25. Petry D.B., Lunney J., Boyd P., Kuhar D., Blankenship E., Johnson R.K. Differential immunity in pigs with high and low responses to porcine reproductive and respiratory syndrome virus infection. Journal of Animal Science 2007, 85:2075-2092.
26. Murtaugh M.P., Johnson C.R., Xiao Z., Scamurra R.W., Zhou Y. Species specialization in cytokine biology: is interleukin-4 central to the T(H)1-T(H)2 paradigm in swine. Developmental and Comparative Immunology 2009, 33:344-352.
27. Diaz I., Darwich L., Pappaterra G., Pujols J., Mateu E. Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. Virology 2006, 351:249-259.
28. Dwivedi V., Manickam C., Binjawadagi B., Linhares D., Murtaugh M.P., Renukaradhya G.J. Evaluation of immune responses to porcine reproductive and respiratory syndrome virus in pigs during early stage of infection under farm conditions. Virology Journal 2012, 9:45.
29. Song S., Bi J., Wang D., Fang L., Zhang L., Li F., et al. Porcine reproductive and respiratory syndrome virus infection activates IL-10 production through NF-kappaB and p38 MAPK pathways in porcine alveolar macrophages. Developmental and Comparative Immunology 2013, 39:265-272.
30. Suradhat S., Thanawongnuwech R. Upregulation of interleukin-10 gene expression in the leukocytes of pigs infected with porcine reproductive and respiratory syndrome virus. Journal of General Virology 2003, 84:2755-2760.
31. Charerntantanakul W., Platt R., Roth J.A. Effects of porcine reproductive and respiratory syndrome virus-infected antigen-presenting cells on T cell activation and antiviral cytokine production. Viral Immunology 2006, 19:646-661.
32. Gerner W., Kaser T., Porcine S.A. T lymphocytes and NK cells - an update. Developmental and Comparative Immunology 2009, 33:310-320.
33. Xiao Z., Batista L., Dee S., Halbur P., Murtaugh M.P. The level of virus-specific T-cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus load. Journal of Virology 2004, 78:5923-5933.